BrightHeart’s AI-based CHD detection platform received FDA clearance in 2024 and is currently being used at a limited range ...
A Bengaluru woman defied the odds, delivering a healthy baby girl despite facing severe pregnancy complications. Doctors ...
BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing of an €11 million Series A financing round. The round was co-led by Odyssée ...
BrightHeart delivers expert-level ultrasound screening for complex organs, helping OB-GYNs improve the detection of ...
AI assistance reduced interpretation time by 48 seconds per examination while increasing clinician confidence scores.
Chennai: A 22-year-old woman's death from complications of congenital heart disease during childbirth ignited a dispute ...
World Class CME, organizer of the new Advanced OB-GYN Ultrasound Symposium, announced their World Class CME In-Person ...
12d
Their baby had little chance of survival. Then Texas Children's offered a novel, in-utero solution.
A Dallas couple turned to Texas Children's Hospital for a complex and high-risk procedure to insert a stent in their son's ...
Re “Doctors Stick With Unreliable Medical Tool to Justify C-Sections” (front page, Nov. 7): As the president of the American College of Obstetricians and Gynecologists, I found that this article, ...
Study Rundown: Fetal anomaly ultrasound (US) screening is a common method used to diagnose congenital malformations antenatally. However, universal detection of major fetal malformations, such as ...
Fetal rhabdomyoma is a rare benign cardiac tumor that primarily occurs during the fetal or neonatal period and is often associated with Tuberous Sclerosis Complex (TSC). It is most commonly found in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback